<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="87231">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01754051</url>
  </required_header>
  <id_info>
    <org_study_id>CLP 4818</org_study_id>
    <secondary_id>CLP 4818</secondary_id>
    <nct_id>NCT01754051</nct_id>
  </id_info>
  <brief_title>A Volumetric Coiling in Aneurysm Registry of the Penumbra Coil 400TM System in France</brief_title>
  <acronym>VOLCAN</acronym>
  <official_title>VOLCAN: A Volumetric Coiling in Aneurysm Registry of the Penumbra Coil 400TM System in France</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Penumbra Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Penumbra Inc.</source>
  <oversight_info>
    <authority>France: Comité de Protection des Personnes (CPP) Ile de France 1</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a prospective, multi-center registry of patients with intracranial aneurysms
      who are treated by the PC 400 System. Data for each patient are collected up to 12 ± 3
      months post-procedure for the study.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Packing density with the number of coils implanted</measure>
    <time_frame>During the procedure</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Time of fluoroscopic exposure</measure>
    <time_frame>During the procedure</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Procedural device-related serious adverse events at immediate post-procedure</measure>
    <time_frame>During the procedure</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of aneurysm occlusion post-operatively and at 12±3 months post-procedure based on the Raymond Scale</measure>
    <time_frame>At 1 year post-procedure</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Acute occlusion of the aneurysm sac at immediate post-procedure</measure>
    <time_frame>At immediate post-procedure</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events occurring during the procedure and in the 30±7 days following   the treatment.</measure>
    <time_frame>During and at 30 days post-procedure</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Intracranial Aneurysms</condition>
  <arm_group>
    <arm_group_label>Treatment by the PC 400 coils</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PC 400 coils</intervention_name>
    <arm_group_label>Treatment by the PC 400 coils</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Up to 200 patients with intracranial aneurysms treated by the PC 400 System at up to 20
        centers will be enrolled.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients older than 18 years

          -  Intracranial aneurysms &gt;2mm, ruptured or unruptured

        Exclusion Criteria:

          -  Fusiform aneurysms

          -  Dissecting aneurysms

          -  Aneurysms associated with brain AVMs

          -  Multiple aneurysms

          -  Re-treated aneurysms

          -  Patients in whom endovascular embolization therapies other than PC 400 System are
             used will be excluded from this study. However, adjunctive use of balloon and stent
             are acceptable.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Prof. Laurent Pierot, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Reims - Hôpital Maison Blanche</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Olivier Sallem, PhD</last_name>
    <phone>33 6 82 33 05 06</phone>
    <email>osellam@penumbrainc.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Siu Po Sit, PhD</last_name>
    <phone>510748 3200</phone>
    <phone_ext>221</phone_ext>
    <email>siupo.sit@penumbrainc.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hôpital Côte de Nacre</name>
      <address>
        <city>Caen Cedex 9</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Prof. Patrick Courthéoux, MD</last_name>
    </contact>
    <investigator>
      <last_name>Prof. Patrick Courthéoux, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Reims - Hôpital Maison Blanche</name>
      <address>
        <city>Reims Cedex</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Prof. Laurent Pierot, MD</last_name>
    </contact>
    <investigator>
      <last_name>Prof. Laurent Pierot, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 19, 2014</lastchanged_date>
  <firstreceived_date>December 17, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Intracranial Aneurysm</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
